Analysts have been eager to weigh in on the Healthcare sector with new ratings on Adaptimmune Therapeutics (ADAP – Research Report), Elevation Oncology (ELEV – Research Report) and AC Immune SA (ACIU – Research Report).
Adaptimmune Therapeutics (ADAP)
Leerink Partners analyst Jonathan Chang reiterated a Hold rating on Adaptimmune Therapeutics on March 6 and set a price target of $2.00. The company’s shares closed last Friday at $1.75.
According to TipRanks.com, Chang is a 4-star analyst with an average return of
Adaptimmune Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $3.40, which is an 89.9% upside from current levels. In a report issued on March 6, Wells Fargo also assigned a Hold rating to the stock with a $2.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Elevation Oncology (ELEV)
In a report issued on March 6, Andrew Berens from Leerink Partners maintained a Buy rating on Elevation Oncology, with a price target of $10.00. The company’s shares closed last Friday at $4.57.
According to TipRanks.com, Berens is a 2-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Elevation Oncology with a $7.75 average price target, which is a 71.5% upside from current levels. In a report issued on March 1, JMP Securities also initiated coverage with a Buy rating on the stock with a $7.00 price target.
AC Immune SA (ACIU)
Leerink Partners analyst Marc Goodman maintained a Buy rating on AC Immune SA on March 6 and set a price target of $9.00. The company’s shares closed last Friday at $3.78.
According to TipRanks.com, Goodman is a 4-star analyst with an average return of
AC Immune SA has an analyst consensus of Moderate Buy, with a price target consensus of $12.50.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ADAP:
